Mast Therapeutics Acquires Aires Pharmaceuticals for Undisclosed Sum

  • Feed Type
  • Date
    2/11/2014
  • Company Name
    Aires Pharmaceuticals
  • Mailing Address
    4365 Executive Drive San Diego, CA 92121
  • Company Description
    As a first product opportunity, the Company is developing an inhaled drug that has been demonstrated in animal models to treat both adult and pediatric pulmonary hypertension. As a second product opportunity, Aires is also pursuing indications associated with the treatment of bacterial pulmonary infections.
  • Website
    http://www.airespharma.com
  • Transaction Type
    M&A
  • Transaction Amount
    Undisclosed
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    The acquisition will be paid for with all stock.

By posting a comment, you agree to our terms and conditions.